Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts

Approved

Publication information

OKM publication type

A1

Category

Artikkelit ja abstraktit

Sub category

Tieteelliset aikakauslehtiartikkelit

Type

Alkuperäisartikkeli

Refereed

Kyllä

Authors of the publication

Authors

Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-Herttuala S et al

Local authors

Author

Ylä-Herttuala Seppo

Unit

A.I. Virtanen -instituutti / Bioteknologia ja molekulaarinen lääketiede

Publication channel information

Title of journal/series

Circulation

Publication forum ID

53475

Internationality

Yes

Detailed publication information

Publication year

2010

Journal/series volume number

121

Page numbers

1413-1422

Language of publication

English

Co-publication information

International co-publication

Yes